Minneapolis, MN-based Humanetics Corporation, has granted an exclusive worldwide license to iSatori Global Technologies, Golden, CA, to create and market products that contain Humanetics’ patent pending technology for increased whole body creatine retention. This technology is based upon combining creatine with specific doses of Inzitol, which is Humanetics’ proprietary d-pinitol ingredient and a natural insulin mediator. iSatori will be the only company licensed to utilize the exact amounts of d-pinitol used in recent clinical studies.